This inventor holds 1 USPTO granted patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Stefan Matysiak
Introduction
Stefan Matysiak is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of bioengineering, particularly in the synthesis of biochips. His innovative approach has led to advancements that could impact various applications in biotechnology.
Latest Patents
One of Matysiak's key inventions is a method for the light-controlled synthesis of biochips. This patent involves a photolithographic synthesis technique that utilizes photolabile protective groups of the 2-(2-nitrophenyl)ethyl type. The method enhances the irradiation step commonly used in photolithographic chip synthesis by conducting it in the presence of a base, preferably a secondary or tertiary base. This innovation is crucial for improving the efficiency and effectiveness of biochip production.
Career Highlights
Stefan Matysiak is affiliated with the German Cancer Research Center (Deutsches Krebsforschungszentrum). His work at this prestigious institution has allowed him to focus on groundbreaking research that bridges the gap between engineering and biological sciences. His dedication to advancing technology in the medical field is evident through his innovative patents.
Collaborations
Matysiak has collaborated with esteemed colleagues such as Markus Beier and Jörg Hoheisel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Stefan Matysiak's contributions to the field of bioengineering, particularly through his patented methods for biochip synthesis, highlight his role as an influential inventor. His work continues to pave the way for advancements in biotechnology and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
